OVERWEIGHT
Clinical trials for OVERWEIGHT explained in plain language.
Never miss a new study
Get alerted when new OVERWEIGHT trials appear
Sign up with your email to follow new studies for OVERWEIGHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weight loss and hormone pill tested for fertility-sparing cancer treatment – but trial stopped early
Disease control TerminatedThis study tested whether combining weight management (diet and exercise guidance) with a daily hormone pill (megestrol acetate) could help obese patients with early-stage endometrial cancer who want to preserve their fertility. The goal was to see if the cancer would completely …
Matched conditions: OVERWEIGHT
Phase: PHASE2, PHASE3 • Sponsor: Xiaojun Chen • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Exercise program targets metabolic risks in cancer survivors
Disease control TerminatedThis study looked at whether a specific type of exercise, combining aerobic and resistance training in short bursts, could improve metabolic health in overweight or obese breast and prostate cancer survivors who had finished treatment. The goal was to reduce insulin resistance an…
Matched conditions: OVERWEIGHT
Phase: NA • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Diet and exercise study for overweight women halted early
Knowledge-focused TerminatedThis study looked at whether an 8-week diet program, with or without aerobic and resistance exercise, could improve balance, muscle pain, physical function, and sleep in overweight women aged 18-50. The trial was terminated early, so results are limited. It was designed to gather…
Matched conditions: OVERWEIGHT
Phase: NA • Sponsor: Bezmialem Vakif University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Diabetes drug may alter your taste buds and food desires
Knowledge-focused TerminatedThis study looked at how the diabetes medication Liraglutide (Victoza) affects taste, food cravings, and eating habits in people with type 2 diabetes who are overweight. Researchers compared three groups: patients starting Liraglutide, diabetic patients not on the drug, and healt…
Matched conditions: OVERWEIGHT
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC